910 related articles for article (PubMed ID: 17290066)
21. TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers.
Le Calvez F; Mukeria A; Hunt JD; Kelm O; Hung RJ; Tanière P; Brennan P; Boffetta P; Zaridze DG; Hainaut P
Cancer Res; 2005 Jun; 65(12):5076-83. PubMed ID: 15958551
[TBL] [Abstract][Full Text] [Related]
22. Epidermal growth factor receptor gene amplification in surgical resected Japanese lung cancer.
Sasaki H; Shimizu S; Okuda K; Kawano O; Yukiue H; Yano M; Fujii Y
Lung Cancer; 2009 Jun; 64(3):295-300. PubMed ID: 19058870
[TBL] [Abstract][Full Text] [Related]
23. Reversed mutation rates of KRAS and EGFR genes in adenocarcinoma of the lung in Taiwan and their implications.
Wu CC; Hsu HY; Liu HP; Chang JW; Chen YT; Hsieh WY; Hsieh JJ; Hsieh MS; Chen YR; Huang SF
Cancer; 2008 Dec; 113(11):3199-208. PubMed ID: 18932251
[TBL] [Abstract][Full Text] [Related]
24. Fumes from meat cooking and lung cancer risk in Chinese women.
Seow A; Poh WT; Teh M; Eng P; Wang YT; Tan WC; Yu MC; Lee HP
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1215-21. PubMed ID: 11097230
[TBL] [Abstract][Full Text] [Related]
25. Never-smokers with lung cancer: epidemiologic evidence of a distinct disease entity.
Toh CK; Gao F; Lim WT; Leong SS; Fong KW; Yap SP; Hsu AA; Eng P; Koong HN; Thirugnanam A; Tan EH
J Clin Oncol; 2006 May; 24(15):2245-51. PubMed ID: 16710022
[TBL] [Abstract][Full Text] [Related]
26. Mutational and epigenetic evidence for independent pathways for lung adenocarcinomas arising in smokers and never smokers.
Toyooka S; Tokumo M; Shigematsu H; Matsuo K; Asano H; Tomii K; Ichihara S; Suzuki M; Aoe M; Date H; Gazdar AF; Shimizu N
Cancer Res; 2006 Feb; 66(3):1371-5. PubMed ID: 16452191
[TBL] [Abstract][Full Text] [Related]
27. GSTM1, P53 and K-ras molecular detection in resectable non-small cell lung cancer by denaturing gradient gel electrophoresis-bronchoalveolar lavage fluid analysis.
Curigliano G; Ferretti G; Mandalà M; De Pas T; Calabrò MG; Solli P; Noberasc C; de Braud F
Anticancer Res; 2001; 21(5):3461-9. PubMed ID: 11848510
[TBL] [Abstract][Full Text] [Related]
28. Loss of heterozygosity of chromosome 3p21 is associated with mutant TP53 and better patient survival in non-small-cell lung cancer.
Marsit CJ; Hasegawa M; Hirao T; Kim DH; Aldape K; Hinds PW; Wiencke JK; Nelson HH; Kelsey KT
Cancer Res; 2004 Dec; 64(23):8702-7. PubMed ID: 15574780
[TBL] [Abstract][Full Text] [Related]
29. Lung cancer and past occupational exposure to asbestos. Role of p53 and K-ras mutations.
Husgafvel-Pursiainen K; Karjalainen A; Kannio A; Anttila S; Partanen T; Ojajärvi A; Vainio H
Am J Respir Cell Mol Biol; 1999 Apr; 20(4):667-74. PubMed ID: 10100998
[TBL] [Abstract][Full Text] [Related]
30. Smoking, occupation and family history in lung cancer patients under fifty years of age.
Tsugane S; Watanabe S; Sugimura H; Arimoto H; Shimosato Y; Suemasu K
Jpn J Clin Oncol; 1987 Dec; 17(4):309-17. PubMed ID: 2826845
[TBL] [Abstract][Full Text] [Related]
31. The TP53 gene, tobacco exposure, and lung cancer.
Toyooka S; Tsuda T; Gazdar AF
Hum Mutat; 2003 Mar; 21(3):229-39. PubMed ID: 12619108
[TBL] [Abstract][Full Text] [Related]
32. Relation of exposure to environmental tobacco smoke and pulmonary adenocarcinoma in non-smoking women: a case control study in Nanjing.
Shen XB; Wang GX; Zhou BS
Oncol Rep; 1998; 5(5):1221-3. PubMed ID: 9683839
[TBL] [Abstract][Full Text] [Related]
33. p53 and K-ras mutations in lung cancers from former and never-smoking women.
Vähäkangas KH; Bennett WP; Castrén K; Welsh JA; Khan MA; Blömeke B; Alavanja MC; Harris CC
Cancer Res; 2001 Jun; 61(11):4350-6. PubMed ID: 11389059
[TBL] [Abstract][Full Text] [Related]
34. Epidermal growth factor receptor abnormalities in lung cancer. Pathogenetic and clinical implications.
Prudkin L; Wistuba II
Ann Diagn Pathol; 2006 Oct; 10(5):306-15. PubMed ID: 16979526
[TBL] [Abstract][Full Text] [Related]
35. Genetic basis for susceptibility to lung cancer: Recent progress and future directions.
Yokota J; Shiraishi K; Kohno T
Adv Cancer Res; 2010; 109():51-72. PubMed ID: 21070914
[TBL] [Abstract][Full Text] [Related]
36. Copy number gains on 5p15, 6p11-q11, 7p12, and 8q24 are rare in sputum cells of individuals at high risk of lung cancer.
Kettunen E; Salmenkivi K; Vuopala K; Toljamo T; Kuosma E; Norppa H; Knuutila S; Kaleva S; Huuskonen MS; Anttila S
Lung Cancer; 2006 Nov; 54(2):169-76. PubMed ID: 16935392
[TBL] [Abstract][Full Text] [Related]
37. Gender and lung cancer.
Rivera MP; Stover DE
Clin Chest Med; 2004 Jun; 25(2):391-400. PubMed ID: 15099898
[TBL] [Abstract][Full Text] [Related]
38. Multiplicity of abnormal promoter methylation in lung adenocarcinomas from smokers and never smokers.
Divine KK; Pulling LC; Marron-Terada PG; Liechty KC; Kang T; Schwartz AG; Bocklage TJ; Coons TA; Gilliland FD; Belinsky SA
Int J Cancer; 2005 Apr; 114(3):400-5. PubMed ID: 15578700
[TBL] [Abstract][Full Text] [Related]
39. Differences between small-cell lung cancer and non-small-cell lung cancer among tobacco smokers.
Toh CK; Gao F; Lim WT; Leong SS; Fong KW; Yap SP; Hsu AA; Eng P; Koong HN; Thirugnanam A; Tan EH
Lung Cancer; 2007 May; 56(2):161-6. PubMed ID: 17270313
[TBL] [Abstract][Full Text] [Related]
40. The prognostic impact of the amount of tobacco smoking in non-small cell lung cancer--differences between adenocarcinoma and squamous cell carcinoma.
Okamoto T; Suzuki Y; Fujishita T; Kitahara H; Shimamatsu S; Kohno M; Morodomi Y; Kawano D; Maehara Y
Lung Cancer; 2014 Aug; 85(2):125-30. PubMed ID: 24976334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
